Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

August’s top stories: CUHK’s EBV-DNA analysis for NPC, Fresenius Medical’s $2bn acquisition

A new Chinese University of Hong Kong (CUHK) study indicated possibility of plasma Epstein-Barr virus (EBV) DNA analysis to detect early asymptomatic nasopharyngeal carcinoma (NPC), and Fresenius Medical Care entered an agreement to purchase US-based firm NxStage Medical for $2bn. Medicaldevice-network.com wraps-up the key headlines from August 2017.

Go Top